发明名称 INTEGRIN EXPRESSION INHIBITORS
摘要 <p>Integrin expression inhibitors and remedies for arteriosclerosis, psoriasis, cancer, retinal angiogenesis, diabetic retinitis or inflammatory diseases, anticoagulant agents and cancerous metastasis inhibitors based on the integrin inhibitory effect. Namely, integrin expression inhibitors containing as the active ingredient sulfonamide compounds represented by the following general formula (I), pharmacologically acceptable salts thereof or hydrates of the same wherein B represents optionally substituted C6-10 aryl or 6- to 10-membered heteroaryl wherein the ring may be partly saturated; K represents a single bond, -CH=CH- or -(CR4bR5b)mb- (wherein R?4b and R5b¿ may be the same or different and each represents hydrogen or C¿1-4? alkyl; and m?b¿ represents an integer of 1 or 2); R1 represents hydrogen or C¿1-6? alkyl; Z represents a single bond or CO-NH-; and R represents optionally substituted C6-10 aryl or 6- to 10-membered heteroaryl wherein the ring may be partly saturated.</p>
申请公布号 WO2001056607(P1) 申请公布日期 2001.08.09
申请号 JP2001000713 申请日期 2001.02.01
申请人 发明人
分类号 主分类号
代理机构 代理人
主权项
地址